ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,431Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 2035

$1.47M Total Retail Price of All Prescriptions

Rank: 16 out of 2035

1,000 Patients Receiving at Least One Drug in Part D
43%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 1,000 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

24% of this provider’s 1,000 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 12,829 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
LEVOTHYROXINE SODIUM 1,252 569 1 4
LISINOPRIL 1,164 525 2 3
HYDROCODONE-ACETAMINOPHEN 1,046 427 S3 3 2
OMEPRAZOLE 998 436 4 5
SIMVASTATIN 958 404 5 1
AMLODIPINE BESYLATE 790 415 6 6
METFORMIN HCL 721 320 7 9
FUROSEMIDE 703 355 8 7
METOPROLOL TARTRATE 686 352 9 8
RANITIDINE HCL 532 176 10 28
POTASSIUM CHLORIDE 466 226 11 18
ATORVASTATIN CALCIUM 396 218 12 13
TRAMADOL HCL 372 134 13 19
GABAPENTIN 368 86 14 14
NEXIUM 347 125 15 51
HYDROCHLOROTHIAZIDE 310 108 16 12
QUETIAPINE FUMARATE 297 144 17 70
IBUPROFEN 285 111 18 43
DIVALPROEX SODIUM 278 79 19 75
SERTRALINE HCL 271 146 20 23
CLOPIDOGREL 262 145 21 30
ISOSORBIDE MONONITRATE ER 261 157 22 32
DONEPEZIL HCL 258 200 23 24
PROAIR HFA 257 79 24 31
LEVETIRACETAM 255 70 25 87
CITALOPRAM HBR 242 144 26 20
ATENOLOL 241 132 27 10
WARFARIN SODIUM 236 152 28 11
TRAZODONE HCL 236 77 28 50
NAMENDA 231 186 30 37
OXYBUTYNIN CHLORIDE 218 110 31 102
CARVEDILOL 216 115 32 22
ENALAPRIL MALEATE 216 73 32 60
TAMSULOSIN HCL 213 106 34 25
ALENDRONATE SODIUM 206 104 35 27
LOVASTATIN 193 67 36 33
ADVAIR DISKUS 192 85 37 38
RISPERIDONE 187 104 38 68
PLAVIX 178 116 39 49
POLYETHYLENE GLYCOL 3350 171 39 40 48
ZOLPIDEM TARTRATE 170 77 41 21
BENZTROPINE MESYLATE 165 51 R 42 223
LANTUS 165 52 42 40
AZITHROMYCIN 154 60 44 39
LACTULOSE 149 56 45 96
CYCLOBENZAPRINE HCL 148 21 R 46 64
CIPROFLOXACIN HCL 141 70 47 63
NIFEDIPINE ER 139 66 48 98
OLANZAPINE 136 50 49 121
LIPITOR 134 63 50 134
NAPROXEN 131 63 51 92
GLIPIZIDE 131 52 51 54
CYMBALTA 131 38 51 59
CLONIDINE HCL 129 63 54 61
LYRICA 128 51 55 89
OXYBUTYNIN CHLORIDE ER 127 44 56 117
ESCITALOPRAM OXALATE 126 48 57 77
ABILIFY 125 30 58 174
PHENYTOIN SODIUM EXTENDED 124 59 59 132
INSULIN SYRINGE 124 12 59 97
MELOXICAM 121 54 61 56
FAMOTIDINE 121 45 61 71
SINGULAIR 120 34 63 119
ZETIA 119 60 64 84
DETROL LA 112 79 65 237
GEMFIBROZIL 111 43 66 114
VENTOLIN HFA 109 46 67 80
CARISOPRODOL 106 0 R 68 57
HYDRALAZINE HCL 105 71 69 45
PREDNISONE 103 63 70 36
FLUOXETINE HCL 103 30 70 81
PAROXETINE HCL 101 74 72 69
NIASPAN 101 25 72 165
DIVALPROEX SODIUM ER 100 0 74 226
TERAZOSIN HCL 98 77 75 149
HALOPERIDOL 98 39 75 301
DIGOXIN 93 47 77 67
CEPHALEXIN 92 40 78 91
MONTELUKAST SODIUM 90 30 79 187
SPIRIVA 90 37 79 44
NOVOLIN R 89 0 81 210
SEROQUEL 88 47 82 153
BUMETANIDE 86 40 83 79
FLUTICASONE PROPIONATE 85 0 84 29
CARBAMAZEPINE 84 17 85 228
SULFAMETHOXAZOLE-TRIMETHOPRIM 82 32 86 110
CELEBREX 81 61 87 104
ACETAMINOPHEN-CODEINE 81 39 S3 87 52
ALLOPURINOL 81 61 87 34
DICYCLOMINE HCL 79 13 90 212
OXCARBAZEPINE 78 20 91 317
NASONEX 76 12 92 207
TRIAMTERENE-HCTZ 76 41 92 35
MIRTAZAPINE 74 41 94 46
SPIRONOLACTONE 71 50 95 65
CALCITRIOL 70 38 96 188
CARBIDOPA-LEVODOPA 69 25 97 94
SURE COMFORT 67 17 98 243
LOSARTAN POTASSIUM 67 20 98 15
MEGESTROL ACETATE 67 41 R 98 175
HYDROCORTISONE 66 29 101 156
VESICARE 66 38 101 209
FLUCONAZOLE 66 33 101 198
BACLOFEN 64 18 104 112
PROPRANOLOL HCL 64 0 104 161
LITHIUM CARBONATE 64 36 104 378
CRESTOR 64 17 104 41
METOCLOPRAMIDE HCL 63 15 108 144
TOPIRAMATE 62 13 109 184
METHOCARBAMOL 60 0 R 110 214
SEROQUEL XR 60 0 110 294
DIOVAN 58 27 112 76
BYSTOLIC 57 34 113 108
MECLIZINE HCL 54 35 114 147
METOPROLOL SUCCINATE 53 29 115 16
LOVAZA 52 31 116 137
KETOCONAZOLE 52 19 116 215
GLIPIZIDE ER 50 32 118 131
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 5, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.